| Followers | 107 |
| Posts | 7699 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2007 |
Friday, September 20, 2024 9:39:32 AM
Recent CRBP News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 09:06:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/09/2026 08:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:30:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 09:08:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:45:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:32:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:30:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2026 09:02:31 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 06:14:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:25:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:24:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:26:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:05:25 PM
- Corbus Pharmaceuticals Shares Rise on Encouraging Safety Results for Experimental Obesity Drug • IH Market News • 12/11/2025 01:28:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 12:22:10 PM
- Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss • GlobeNewswire Inc. • 12/11/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:14:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 01:02:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/03/2025 01:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:34:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/30/2025 08:33:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2025 08:23:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/24/2025 08:18:02 PM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
